Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients
Jpn J Clin Oncol
.
2021 Jul 1;51(7):1183.
doi: 10.1093/jjco/hyab092.
Authors
Yuki Takeyasu
1
2
,
Tatsuya Yoshida
1
,
Noriko Motoi
3
4
,
Takashi Teishikata
3
,
Midori Tanaka
5
,
Yuji Matsumoto
1
5
,
Yuki Shinno
1
,
Yusuke Okuma
1
,
Yasushi Goto
1
,
Hidehito Horinouchi
1
,
Hiroki Kakishima
3
,
Takaaki Tsuchida
5
,
Noboru Yamamoto
1
,
Yuichiro Ohe
1
,
Yasushi Yatabe
3
Affiliations
1
Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
2
Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
3
Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan.
4
Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
5
Department of Endoscopy, Respiratory Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
PMID:
34100088
DOI:
10.1093/jjco/hyab092
No abstract available
Publication types
Published Erratum